Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alen Marijam

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Infectious Diseases and Therapy|November 26, 2024
Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation ProgrammeManjit Hunjan, Desmond Curran, Alen Marijam, et al.
Value in Health Regional Issues|February 19, 2019
Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish ChildrenAlen Marijam, Jan Olbrecht, Alev Ozakay, et al.
Plos One|September 26, 2024
Allergies to antibiotics among US women with uncomplicated urinary tract infectionAshish V Joshi, Alen Marijam, Fanny S Mitrani-Gold, et al.
Vaccines|April 23, 2025
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Infectious Diseases and Therapy|April 24, 2024
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UKAlen Marijam, Nikki Vroom, Amit Bhavsar, et al.
Expert Review of Vaccines|March 21, 2020
Ten years of experience with the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine (<i>Synflorix</i>) in childrenNicolas Lecrenier, Alen Marijam, Jan Olbrecht, et al.
Plos One|February 1, 2023
Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United StatesJeffrey Thompson, Alen Marijam, Fanny S Mitrani-Gold, et al.
Human Vaccines & Immunotherapeutics|October 1, 2025
The relationship between socio-economic inequity indicators and 4CMenB vaccination rates in infants and adolescents in Spain: An ecological correlation studyGeorgios Nikitas, Laura A Vallejo, Andrew G Allmon, et al.
Journal of Market Access & Health Policy|March 5, 2020
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the futureBaudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, et al.
Plos One|January 8, 2025
Activity impairment, work productivity, health-related quality-of-life, and costs associated with uncomplicated urinary tract infection among females in GermanyMegan O'Brien, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Infectious Diseases and Therapy|November 26, 2024
Modelled Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the UK National Immunisation ProgrammeManjit Hunjan, Desmond Curran, Alen Marijam, et al.
Value in Health Regional Issues|February 19, 2019
Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish ChildrenAlen Marijam, Jan Olbrecht, Alev Ozakay, et al.
Plos One|September 26, 2024
Allergies to antibiotics among US women with uncomplicated urinary tract infectionAshish V Joshi, Alen Marijam, Fanny S Mitrani-Gold, et al.
Vaccines|April 23, 2025
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in ItalyAnna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Infectious Diseases and Therapy|April 24, 2024
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UKAlen Marijam, Nikki Vroom, Amit Bhavsar, et al.
Expert Review of Vaccines|March 21, 2020
Ten years of experience with the pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine (<i>Synflorix</i>) in childrenNicolas Lecrenier, Alen Marijam, Jan Olbrecht, et al.
Plos One|February 1, 2023
Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United StatesJeffrey Thompson, Alen Marijam, Fanny S Mitrani-Gold, et al.
Human Vaccines & Immunotherapeutics|October 1, 2025
The relationship between socio-economic inequity indicators and 4CMenB vaccination rates in infants and adolescents in Spain: An ecological correlation studyGeorgios Nikitas, Laura A Vallejo, Andrew G Allmon, et al.
Journal of Market Access & Health Policy|March 5, 2020
How to assess for the full economic value of vaccines? From past to present, drawing lessons for the futureBaudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, et al.
Plos One|January 8, 2025
Activity impairment, work productivity, health-related quality-of-life, and costs associated with uncomplicated urinary tract infection among females in GermanyMegan O'Brien, Alen Marijam, Fanny S Mitrani-Gold, et al.
Pageof 4